Physician profile
Forrest Pendleton Allen
NPI 1295081065
$8,110.03
in general payments reported to CMS, 2019-2025
29 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $281 · 2021: $3,771 · 2022: $663 · 2023: $638 · 2024: $843 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,966.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,798.35 | 2021-2022 | |
| Medtronic, INC. | $1,060.93 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $993.87 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Curonix LLC | $825.71 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $660.93 | 2020-2024 | Proclaim, Eterna |
| Nevro Corp. | $539.68 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $426.73 | 2021-2025 | Exparel, Iovera, Zilretta |
| Stimwave Technologies Incorporated | $368.76 | 2019-2022 | |
| Relievant Medsystems, INC. | $256.84 | 2019-2023 | Intracept |
| Spr Therapeutics, INC | $253.07 | 2021-2023 | Sprint Pns System |
| Vertos Medical, INC. | $191.75 | 2021-2024 | Mild Device Kit |
| Mml US, INC. | $173.45 | 2025 | Reactiv8 |
| Osteocentric Technologies, INC. | $95.38 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Abbvie INC. | $59.42 | 2024 | |
| Scilex Pharmaceuticals INC. | $58.35 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $49.13 | 2020 | |
| Amgen INC. | $37.02 | 2020-2021 | |
| Horizon Therapeutics Plc | $36.25 | 2019 | |
| Medtronic USA, INC. | $29.12 | 2020 | |
| Si-Bone, INC. | $28.43 | 2021 | |
| Nalu Medical, INC. | $26.26 | 2022 | |
| Vertiflex, INC. | $21.89 | 2019 | |
| Lilly USA, LLC | $21.54 | 2020 | |
| Djo, LLC | $21.24 | 2021 | |
| Smith+Nephew, INC. | $18.38 | 2021 | |
| Depuy Synthes Sales INC. | $16.10 | 2021 | |
| Electronic Waveform Lab, INC. | $14.77 | 2021 | |
| Avanos Medical | $13.69 | 2022 | |
| Radius Health, INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forrest Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.